Mode
Text Size
Log in / Sign up

Keratoconus is associated with increased ocular surface symptoms and dry eye indicatorsPeople with keratoconus experience more severe dry eye symptoms

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize that patients with keratoconus frequently experience higher levels of ocular surface symptoms.

The study investigated the relationship between keratoconus and various ocular surface indicators, including tear break-up time and Schirmer test results. The primary focus was on the OSDI scores to quantify the severity of ocular surface symptoms in patients with keratoconus compared to a control group.

Results indicated that patients with keratoconus experienced significantly higher ocular surface symptoms. While some measures of tear break-up time were lower in the keratoconus group, these specific findings did not reach statistical significance. Other metrics, such as Schirmer test results and noninvasive tear break-up time, showed varied results or lacked sufficient data for a pooled calculation.

Several limitations were noted, including inconsistent testing procedures and issues with data independence in certain studies. Because of these inconsistencies, some pooled estimates could not be calculated. Clinicians should recognize the association between keratoconus and increased ocular surface symptoms when managing these patients, while remaining mindful of the variability in tear film stability measurements.

Living with keratoconus, a condition where the cornea thins and curves, can often come with extra challenges for your eyes. New data shows that people with this condition report significantly higher scores for ocular surface symptoms. This means they often feel more discomfort, irritation, or dryness than people without keratoconus.

Researchers looked at 359 people with keratoconus and 333 people without it. They found a clear link between the condition and higher levels of surface symptoms. While some other tests for tear production showed lower numbers for those with keratoconus, the results were not consistent enough to be certain.

Because the data for some specific tests were limited or inconsistent, we cannot say exactly how much tear production varies for everyone. However, the clear link to higher surface symptoms highlights why managing eye comfort is so important for those living with keratoconus. Talk to your eye doctor about these specific symptoms.

What this means for you:
People with keratoconus report significantly more dry eye symptoms and surface irritation.

Common questions

Does keratoconus cause dry eye symptoms?

Yes, the data shows that people with keratoconus have significantly higher scores for ocular surface symptoms. This means they experience more irritation and discomfort. While the study shows a link between the two, you should speak with your eye doctor to manage your specific symptoms.

How much more discomfort do people with keratoconus feel?

People with keratoconus scored significantly higher on the OSDI scale, which measures surface symptoms. The difference was about 19.45 points compared to those without the condition. This confirms that surface discomfort is a common experience for those with keratoconus.

Are there different types of tear tests for keratoconus?

Several tests were looked at, including fluorescein TBUT and Schirmer I tests. While some results were lower for those with keratoconus, they were not all statistically significant or consistent enough to provide a clear pooled estimate. Your doctor can perform these tests to check your specific tear production.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
BackgroundOcular-surface abnormalities are increasingly recognized in keratoconus (KC), but the magnitude and consistency of these changes remain uncertain. We evaluated ocular-surface symptoms, tear-function parameters, and dry-eye-related categorical outcomes in patients with KC compared with non-KC controls.MethodsPubMed, Embase, Web of Science, and the Cochrane Library were searched from inception through September 1, 2026. Comparative studies reporting the Ocular Surface Disease Index (OSDI), fluorescein tear break-up time (TBUT), noninvasive TBUT (NITBUT), the Schirmer I test (SIT), or a defined dry eye disease (DED) classification were eligible. Meibomian gland dysfunction (MGD) and meibomian gland atrophy (MGA), when reported by otherwise eligible studies, were summarized as secondary ocular-surface findings. Two reviewers independently screened studies, extracted data, and assessed methodological quality using an adapted Newcastle–Ottawa Scale (NOS). Continuous outcomes were quantitatively pooled when the analysis unit and measurement methods were sufficiently defined and comparable; otherwise, study-level findings were summarized without calculating a pooled estimate. Random-effects models were estimated by restricted maximum likelihood with Hartung-Knapp adjustment.ResultsSeven studies involving 359 participants with KC and 333 controls were included. OSDI scores were significantly higher in KC (MD, 19.45 points; 95% CI, 12.27 to 26.63; I2 = 79.9%). Fluorescein TBUT was shorter, although the pooled difference was not statistically significant (MD, −2.74 s; 95% CI, −7.81 to 2.32; I2 = 93.8%). All three studies reporting NITBUT found lower values in KC, but eye selection or data aggregation was unclear in two studies; therefore, a pooled NITBUT estimate was not calculated. SIT findings varied across studies, and a pooled estimate was not calculated because statistical independence of eye-level data and sufficiently comparable testing procedures could not be established across an adequate number of studies. The OSDI finding remained robust across sensitivity and leave-one-out analyses.ConclusionsPatients with KC had higher OSDI scores. The pooled difference in fluorescein TBUT was not statistically significant. Lower NITBUT and SIT values were reported in several studies, but pooled estimates for these outcomes were not calculated because of limitations in eye-level data handling and measurement comparability. Larger prospective multicenter studies using clearly defined analysis units and standardized tear-testing protocols are needed.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD420261282391.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.